Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
Identifieur interne : 002999 ( Main/Exploration ); précédent : 002998; suivant : 002A00Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
Auteurs : Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-05-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Apathy, Deep Brain Stimulation (adverse effects), Dopamine, Dopamine Agonists (therapeutic use), Female, Humans, Indoles (pharmacology), Indoles (therapeutic use), Male, Middle Aged, Mood Disorders (etiology), Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson Disease (psychology), Parkinson disease, Receptors, Dopamine D2 (drug effects), Receptors, Dopamine D3 (drug effects), Subthalamic Nucleus (physiopathology), apathy, dopaminergic agonist, subthalamic stimulation.
- MESH :
- chemical , drug effects : Receptors, Dopamine D2, Receptors, Dopamine D3.
- chemical , pharmacology : Indoles.
- chemical , therapeutic use : Dopamine Agonists, Indoles.
- adverse effects : Deep Brain Stimulation.
- drug therapy : Parkinson Disease.
- etiology : Mood Disorders.
- physiopathology : Parkinson Disease, Subthalamic Nucleus.
- psychology : Parkinson Disease.
- Aged, Female, Humans, Male, Middle Aged.
Abstract
To evaluate the effects of the dopamine D2‐D3 agonist ropinirole in patients who developed apathy after complete withdrawal from dopaminergic medication following successful subthalamic nucleus (STN) stimulation for advanced Parkinson disease (PD). We assessed apathy (Apathy Scale, Apathy Inventory), mood (Montgomery‐Åsberg Depression Rating Scale), cognitive functions (Mattis Dementia rating scale, frontal score, executive tests) and motor state (UPDRS‐III) in 8 PD patients treated with STN stimulation without dopaminergic treatment and who became apathetic. Assessments were made at baseline and after 6 weeks of ropinirole treatment (7.2 ± 5.9 mg/d; range 1–18 mg/d). Apathy improved with ropinirole in all but 1 patient (54 ± 24%; range 0–78%). Mood also improved (75 ± 31%; range 0–100%), but not in correlation with the change in apathy. Cognitive performance was not modified. Stimulation contacts were located within the STN in all patients except the one who remained apathetic in spite of ropinirole treatment (zona incerta). We suggest that apathy, which was compensated for by an enhancement of D2‐D3 receptor stimulation in PD patients with STN stimulation: (1) depends on a dopaminergic deficit in associativo‐limbic areas of the brain and (2) can be avoided if a dopaminergic agonist is administered postoperatively. © 2008 Movement Disorder Society
Url:
- https://api.istex.fr/document/ED91C023356D1D4FFF7501D9DD48101CF35B1793/fulltext/pdf
- https://hal.inria.fr/hal-00805452
DOI: 10.1002/mds.21949
Affiliations:
- France, Suisse
- Canton de Berne, Île-de-France
- Berne, Paris
- Hôpital de la Salpêtrière, Université Pierre-et-Marie-Curie
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001B36
- to stream Istex, to step Curation: 001B36
- to stream Istex, to step Checkpoint: 001557
- to stream Hal, to step Corpus: 000005
- to stream Hal, to step Curation: 000005
- to stream Hal, to step Checkpoint: 000036
- to stream PubMed, to step Corpus: 002263
- to stream PubMed, to step Curation: 002263
- to stream PubMed, to step Checkpoint: 002434
- to stream Ncbi, to step Merge: 002098
- to stream Ncbi, to step Curation: 002098
- to stream Ncbi, to step Checkpoint: 002098
- to stream Main, to step Merge: 003579
- to stream PascalFrancis, to step Corpus: 001245
- to stream PascalFrancis, to step Curation: 001A74
- to stream PascalFrancis, to step Checkpoint: 001366
- to stream Main, to step Merge: 003974
- to stream Main, to step Curation: 002999
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom</title>
<author><name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name>
</author>
<author><name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
</author>
<author><name sortKey="Yaici, Sadek" sort="Yaici, Sadek" uniqKey="Yaici S" first="Sadek" last="Yaici">Sadek Yaici</name>
</author>
<author><name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Lévy">Richard Lévy</name>
</author>
<author><name sortKey="Bardinet, Eric" sort="Bardinet, Eric" uniqKey="Bardinet E" first="Eric" last="Bardinet">Eric Bardinet</name>
</author>
<author><name sortKey="Yelnik, Jerome" sort="Yelnik, Jerome" uniqKey="Yelnik J" first="Jérôme" last="Yelnik">Jérôme Yelnik</name>
</author>
<author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
</author>
<author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation><country>France</country>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:ED91C023356D1D4FFF7501D9DD48101CF35B1793</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21949</idno>
<idno type="url">https://api.istex.fr/document/ED91C023356D1D4FFF7501D9DD48101CF35B1793/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001B36</idno>
<idno type="wicri:Area/Istex/Curation">001B36</idno>
<idno type="wicri:Area/Istex/Checkpoint">001557</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Czernecki V:apathy:following:subthalamic</idno>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-00805452</idno>
<idno type="url">https://hal.inria.fr/hal-00805452</idno>
<idno type="wicri:Area/Hal/Corpus">000005</idno>
<idno type="wicri:Area/Hal/Curation">000005</idno>
<idno type="wicri:Area/Hal/Checkpoint">000036</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Czernecki V:apathy:following:subthalamic</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18398913</idno>
<idno type="wicri:Area/PubMed/Corpus">002263</idno>
<idno type="wicri:Area/PubMed/Curation">002263</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002434</idno>
<idno type="wicri:Area/Ncbi/Merge">002098</idno>
<idno type="wicri:Area/Ncbi/Curation">002098</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002098</idno>
<idno type="wicri:Area/Main/Merge">003579</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0305133</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001245</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A74</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001366</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Czernecki V:apathy:following:subthalamic</idno>
<idno type="wicri:Area/Main/Merge">003974</idno>
<idno type="wicri:Area/Main/Curation">002999</idno>
<idno type="wicri:Area/Main/Exploration">002999</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom</title>
<author><name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Center d'Investigation Clinique, Fédération de Neurologie, INSERM Unit 679, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM Unit 610, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Center d'Investigation Clinique, Fédération de Neurologie, INSERM Unit 679, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Neurology, University Hospital, Bern</wicri:regionArea>
<placeName><settlement type="city">Berne</settlement>
<region type="région" nuts="3">Canton de Berne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yaici, Sadek" sort="Yaici, Sadek" uniqKey="Yaici S" first="Sadek" last="Yaici">Sadek Yaici</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Center d'Investigation Clinique, Fédération de Neurologie, INSERM Unit 679, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Lévy">Richard Lévy</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM Unit 610, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bardinet, Eric" sort="Bardinet, Eric" uniqKey="Bardinet E" first="Eric" last="Bardinet">Eric Bardinet</name>
<affiliation wicri:level="4"><country xml:lang="fr">France</country>
<wicri:regionArea>CNRS‐UPR640, CHU Pitié‐Salpêtrière, Université Pierre et Marie Curie‐Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yelnik, Jerome" sort="Yelnik, Jerome" uniqKey="Yelnik J" first="Jérôme" last="Yelnik">Jérôme Yelnik</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Center d'Investigation Clinique, Fédération de Neurologie, INSERM Unit 679, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM Unit 610, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Center d'Investigation Clinique, Fédération de Neurologie, INSERM Unit 679, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-05-15">2008-05-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="964">964</biblScope>
<biblScope unit="page" to="969">969</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">ED91C023356D1D4FFF7501D9DD48101CF35B1793</idno>
<idno type="DOI">10.1002/mds.21949</idno>
<idno type="ArticleID">MDS21949</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Apathy</term>
<term>Deep Brain Stimulation (adverse effects)</term>
<term>Dopamine</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Indoles (pharmacology)</term>
<term>Indoles (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Mood Disorders (etiology)</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson disease</term>
<term>Receptors, Dopamine D2 (drug effects)</term>
<term>Receptors, Dopamine D3 (drug effects)</term>
<term>Subthalamic Nucleus (physiopathology)</term>
<term>apathy</term>
<term>dopaminergic agonist</term>
<term>subthalamic stimulation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Dopamine D2</term>
<term>Receptors, Dopamine D3</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Indoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term>
<term>Indoles</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Deep Brain Stimulation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Mood Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
<term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Apathie</term>
<term>Dopamine</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To evaluate the effects of the dopamine D2‐D3 agonist ropinirole in patients who developed apathy after complete withdrawal from dopaminergic medication following successful subthalamic nucleus (STN) stimulation for advanced Parkinson disease (PD). We assessed apathy (Apathy Scale, Apathy Inventory), mood (Montgomery‐Åsberg Depression Rating Scale), cognitive functions (Mattis Dementia rating scale, frontal score, executive tests) and motor state (UPDRS‐III) in 8 PD patients treated with STN stimulation without dopaminergic treatment and who became apathetic. Assessments were made at baseline and after 6 weeks of ropinirole treatment (7.2 ± 5.9 mg/d; range 1–18 mg/d). Apathy improved with ropinirole in all but 1 patient (54 ± 24%; range 0–78%). Mood also improved (75 ± 31%; range 0–100%), but not in correlation with the change in apathy. Cognitive performance was not modified. Stimulation contacts were located within the STN in all patients except the one who remained apathetic in spite of ropinirole treatment (zona incerta). We suggest that apathy, which was compensated for by an enhancement of D2‐D3 receptor stimulation in PD patients with STN stimulation: (1) depends on a dopaminergic deficit in associativo‐limbic areas of the brain and (2) can be avoided if a dopaminergic agonist is administered postoperatively. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
<li>Suisse</li>
</country>
<region><li>Canton de Berne</li>
<li>Île-de-France</li>
</region>
<settlement><li>Berne</li>
<li>Paris</li>
</settlement>
<orgName><li>Hôpital de la Salpêtrière</li>
<li>Université Pierre-et-Marie-Curie</li>
</orgName>
</list>
<tree><country name="France"><noRegion><name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name>
</noRegion>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<name sortKey="Bardinet, Eric" sort="Bardinet, Eric" uniqKey="Bardinet E" first="Eric" last="Bardinet">Eric Bardinet</name>
<name sortKey="Czernecki, Virginie" sort="Czernecki, Virginie" uniqKey="Czernecki V" first="Virginie" last="Czernecki">Virginie Czernecki</name>
<name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Lévy">Richard Lévy</name>
<name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
<name sortKey="Yaici, Sadek" sort="Yaici, Sadek" uniqKey="Yaici S" first="Sadek" last="Yaici">Sadek Yaici</name>
<name sortKey="Yelnik, Jerome" sort="Yelnik, Jerome" uniqKey="Yelnik J" first="Jérôme" last="Yelnik">Jérôme Yelnik</name>
</country>
<country name="Suisse"><region name="Canton de Berne"><name sortKey="Schupbach, Michael" sort="Schupbach, Michael" uniqKey="Schupbach M" first="Michael" last="Schüpbach">Michael Schüpbach</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002999 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002999 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:ED91C023356D1D4FFF7501D9DD48101CF35B1793 |texte= Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom }}
This area was generated with Dilib version V0.6.23. |